Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Revenue:    
Products, services, other $ 1,729,343 $ 2,002,365
Total revenue 1,729,343 2,002,365
Costs and expenses:    
Cost of products and services 2,014,004 942,383
Research and development 969,532 1,101,509
Selling and marketing 401,444 324,728
General and administrative 3,242,652 3,818,892
Total operating costs 6,627,632 6,187,512
Operating loss (4,898,289) (4,185,147)
Other (expense) income:    
Interest expense, net (10,438,565) (14,450,241)
Unrealized (loss) gain on investment in equity securities 3,662 (457,025)
Gain (loss) on extinguishment of liabilities (751,335) (1,061,073)
Other income (expense) 7,849
Total other expense (11,178,389) (15,968,339)
Net loss (16,076,678) (20,153,486)
Deemed dividends on beneficial conversion feature (873,798)
Preferred stock dividends (1,727,275) (1,658,175)
Net loss attributable to common shareholders $ (17,803,953) $ (22,685,459)
Basic and diluted net loss per share attributable to common shareholders $ (1.61) $ (3.42)
Weighted average common shares outstanding used in the basic and diluted net loss per share calculation 11,058,356 6,636,523